Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Sandoz Eyes Doubling Of Japan Business Despite Price Pressures

Executive Summary

Sandoz is bullish on the prospects for its Japanese business, helped by an operating environment it sees as favoring generics and biosimilars and despite growing cost control pressures.


Related Content

Billions At Stake As Generic Approvals Open Up Japan Big Sellers
FDA Claims Sole Authority Over Naming Of US-Licensed Biologics


Related Companies